Contributors: Colin McDermott, Anthony Metke, Spencer Coronado As the healthcare sector continues to operate affected by the coronavirus (“COVID-19”) pandemic, insights and experiences from the provider sector are particularly interesting. In this three-part series, VMG Health has summarized key observations regarding the following three major themes from public healthcare firms: Part 1: COVID-19’s impact on… Read More

Contributors: Madison Whyde, Alex Malin, Chris Madden Among the companies covered for Q3 2020, there was a continued emphasis on expense management and cost savings strategies. As mentioned in Part 1, COVID-19 restrictions began to ease up in many markets with patient volume reapproaching normalized levels. While many companies are still experiencing increased costs related… Read More

Written by Grace McWatters, Victor McConnell, MAI, ASA, CRE, Larry Snyder, MAI Largely driven by growth in the biotechnology research and development segment, real estate associated with the life sciences, which utilizes a combination of office, flex, and lab space, has emerged as a highly favored asset. Accounting for approximately 100 million square feet of… Read More

Contributors: Savanna Dinkel, Blake Madden and Keith Ponsler As the healthcare sector continues to operate affected by the coronavirus (“COVID-19”) pandemic, insights and experiences from the provider sector are particularly interesting. In a three-part series over the coming weeks, VMG will summarize key observations and common themes from public healthcare firms on the following topics:… Read More

The finalized Radiation Oncology payment model and the Final CY 2021 Medicare Physician Fee Schedule (“MPFS”) have now been made public. Many in the industry will continue to face downward pressure on reimbursement during the coming year under the new MPFS payment rates set by Medicare which will drive overall cuts estimated to average 5.0%… Read More

Several changes to the healthcare industry are coming to a head at the same time, creating a perfect storm for physician compensation professionals. One question for these individuals looms large: have market physician compensation and productivity surveys lost their luster? The impacts of the novel coronavirus (“COVID-19” or “COVID”), significant proposed changes to the 2021… Read More

Contributors: Anthony Metke and Spencer Coronado VMG Health has completed its review of healthcare Q2 earnings season, which was one of the most unpredictable quarters for providers and payors to-date. Given that the pandemic impacted the entirety of the second quarter, insights and experiences from the provider sector are particularly interesting. In this three-part series,… Read More

Written by Ashley Dyke & Jordan Tussy The future of the 340B Program remains up in the air as policy makers continue to scrutinize its reimbursement model, citing a potential contribution to rising drug costs and a shift in site-of-service for cancer treatment.8,20 Will the uncertainty of 340B disincentivize hospital consolidation of oncology practices? Is… Read More

With significant changes to relative value unit (“RVU”) values proposed to take effect in 2021, the time for hospitals and health systems to prepare for action is now. Proposed CMS Physician Fee Schedule Changes In August, the Centers for Medicare & Medicaid Services (“CMS”) released proposed changes to the Medicare physician fee schedule that will… Read More

Contributors: Madison Whyde, Alex Malin & Chris Madden As discussed in Part One, volume levels have been significantly impacted by elective procedure suspensions, reduced operating hours, and other restrictive measures such as shelter-in-place and social distancing guidelines, which has placed additional emphasis on expense management and overall profitability. In Part Two of this three-part series,… Read More